Capital Investment Advisory Services, LLC Zynerba Pharmaceuticals, Inc. Transaction History

Capital Investment Advisory Services, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 04, 2020	SELL	$5.61 - $8.57 $5,037 - $7,695	-898 Closed	0 $0
Q1 2019 Apr 23, 2019	BUY	$3.6 - $6.22 $1,800 - $3,110	500 Added 125.63%	898 $5,000
Q4 2018 Feb 04, 2019	BUY	$2.89 - $7.91 $1,150 - $3,148	398 New	398 $1,000

774K

Ticker ZYNE
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,753,100
Description
Zynerba Pharmaceuticals, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically-produced cannabidiol formulated as a permeation-enhanced gel for t...

Get notified when there are updates to the investment portfolio of Capital Investment Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisory Services, LLC with notifications on news.